바이오테크 보도자료
-
- Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities
- Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San Diego laboratory has achieved College of American Pathologists (CAP) accreditatio...
- 01월 21일 15:20
-
- WEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I-IV Trial Delivery Capabilities
- WEP Clinical (WEP) , a full-service contract research organization (CRO), announces the acquisition of Siron Clinical (Siron) , a Netherlands-based European CRO specializing in flexible, high-quality clinica...
- 01월 18일 13:45
-
- Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness
- Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is designed to a...
- 01월 16일 15:10
-
- QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials
- QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of Oracle Argus, a premier pharmacovigilance ...
- 01월 16일 11:20
-
- Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
- Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with parti...
- 01월 15일 10:40
-
- Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference
- Samsung Epis Holdings (KRX: 0126Z0) today shared corporate progress and updates at the 44th J.P. Morgan Healthcare Conference. “2026 is a monumental year for us, as we enter into a new chapter for our compan...
- 01월 15일 10:03
-
- BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference
- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will outline the pillars of its growing global oncology leadership during its presentation today at the 44th Annual J....
- 01월 14일 15:20
-
- Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to ...
- 01월 13일 14:00
-
- MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis
- MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (F...
- 01월 11일 10:45
전시회
